APA (7th ed.) Citation

Zhu, X., Ye, S., Yu, D., Zhang, Y., Li, J., Zhang, M., . . . Kong, L. (2021). Physalin B attenuates liver fibrosis via suppressing LAP2α–HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. British journal of pharmacology, 178(17), 3428-3447. https://doi.org/10.1111/bph.15490

Chicago Style (17th ed.) Citation

Zhu, Xiaoyun, et al. "Physalin B Attenuates Liver Fibrosis via Suppressing LAP2α–HDAC1‐mediated Deacetylation of the Transcription Factor GLI1 and Hepatic Stellate Cell Activation." British Journal of Pharmacology 178, no. 17 (2021): 3428-3447. https://doi.org/10.1111/bph.15490.

MLA (9th ed.) Citation

Zhu, Xiaoyun, et al. "Physalin B Attenuates Liver Fibrosis via Suppressing LAP2α–HDAC1‐mediated Deacetylation of the Transcription Factor GLI1 and Hepatic Stellate Cell Activation." British Journal of Pharmacology, vol. 178, no. 17, 2021, pp. 3428-3447, https://doi.org/10.1111/bph.15490.